Literature DB >> 24884981

Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening?

Monika Komar1, Maria Olszowska, Tadeusz Przewłocki, Jakub Podolec, Jakub Stępniewski, Bartosz Sobień, Rafał Badacz, Anna Kabłak-Ziembicka, Lidia Tomkiewicz-Pająk, Piotr Podolec.   

Abstract

BACKGROUND: Persistent foramen ovale (PFO) is considered a cause of cryptogenic stroke and a risk factor for neurological events in young patients. The reference standard for identifying a PFO is contrast-enhanced transesophageal echocardiography (TEE).The goal of this study was to evaluate the feasibility of transcranial color Doppler (TCD) and its diagnostic sensitivity compared with TEE.
METHODS: We investigated 420 patients admitted to our department with cryptogenic stroke, transient ischemic attacks or other neurological symptoms. All patients underwent TCD and TEE evaluation. TCD and TEE examinations were performed according to a standardized procedure: air-mixed saline was injected into the right antecubital vein three times, while the Doppler signal was recorded during the Valsalva maneuver. During TCD the passage of contrast into the right-middle cerebral artery was recorded 25 seconds following the Valsalva maneuver.
RESULTS: We detected a right-to-left shunt in 220 patients (52.3%) and no-shunts in 159 patients (37.9%) with both TCD and TEE. In 20 (4.8%) patients TEE did not reveal contrast passage which was then detected by TCD. In 21 (5.0%) patients only TEE revealed a PFO. The feasibility of both methods was 100%. TCD had a sensitivity of 95% and a specificity of 92% in the diagnosis of PFO.
CONCLUSIONS: TCD has a relatively good sensitivity and specificity. TCD and TEE are complementary diagnostic tests for PFO, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost and high feasibility.

Entities:  

Mesh:

Year:  2014        PMID: 24884981      PMCID: PMC4046065          DOI: 10.1186/1476-7120-12-16

Source DB:  PubMed          Journal:  Cardiovasc Ultrasound        ISSN: 1476-7120            Impact factor:   2.062


Background

Persistent foramen ovale (PFO) is considered a cause of cryptogenic stroke and a risk factor for neurological events in patients under 40 years of age. PFO has been also associated with several disease processes such as arterial gas embolism due to decompression, or platypnea-orthodeoxia syndrome [1-4]. Although the clinical significance of PFO in relation to cryptogenic stroke is still debated, identification and assessment of this abnormality are nowadays a routine diagnostic procedure. Agitated saline serum has been used in transthoracic echocardiography (TTE), transesophageal echocardiography (TEE) and transcranial color Doppler ultrasound (TCD) for the detection of intracardiac shunts. The reference standard for identifying a PFO is contrast-enhanced TEE but it is a semi-invasive, inconvenient and stressful for the patients and also quite expensive procedure. Some studies have analyzed the most suitable strategy for the screening, diagnosis and quantification of PFO [5-8]. The aim of this study was to evaluate the feasibility of transcranial Doppler and its diagnostic sensitivity compared with transesophageal echocardiography.

Methods

Patient population

We investigated 420 consecutive patients [(260 females, 160 males); mean age 34.8 ± 16.7 (13, 65) years] admitted to our department with cryptogenic stroke, transient ischaemic attacks (TIA) or other neurological symptoms between 2007 and 2014. Most patients (over 50%) had a history of TIA. The main demographic characteristics of the patients are summarized in Table 1.
Table 1

Demographic characteristics of the patients

 Patients (n = 420)
Smoking
205 (48.8%)
Obesity
72 (17.4%)
Diabetes mellitus
19 (4.5%)
Hypertension
64 (15.2%)
Dyslipidemia29 (6.9%)
Demographic characteristics of the patients

Protocol

All patients underwent TCD and TEE evaluation. The studies were performed on the same day by two different experienced cardiologists, unaware with respect to the result of the other study. The patients were examined in the fasting state. Written informed consent was obtained from all patients. The patients were in left lateral decubitus position during both studies. The studies were performed at resting state and during the Valsalva maneuver after contrast injection. The patients had been trained in performing the Valsalva maneuver before study. The training phase included up to 5 Valsalva maneuver attempts, with at least two resulting in septal shifting or reduced middle cerebral artery flow velocity which was followed by contrast injection and the Valsalva maneuver solicited. The study was repeated at least three times.

Agitated saline contrast test

TCD and TEE examinations were performed according to a standardized procedure. In brief, 10 mL of air-mixed saline was injected into the right antecubital vein at three different times, while the Doppler signal was recorded during the Valsalva maneuver. During TCD the passage of contrast into the right-middle cerebral artery was recorded 25 seconds after the Valsalva maneuver. A mixture of 9 mL physiological saline and 1 mL air was agitated 10 times in 2 10-mL syringes connected to a 3-way stopcock to exchange the air-saline mix and achieve good dilution. The bolus of saline solution was prepared and injected by the same nurse using the same method in all studies. The patients started the maneuver about 5 seconds after contrast injection, pressing against the closed glottis for at least 10 seconds. They then performed a deep expiration and inspiration, followed by a deep expiration.

Transcranial doppler ultrasonography

A baseline TCD examination was performed with a Toshiba Power Vision echo-machine using a 2-MHz probe, according to standard practice guidelines. Middle cerebral artery flow was monitored through the temporal bone window. The middle cerebral artery was identified with color Doppler in its proximal portion and insonated bilaterally (Figure 1). On TCD study, the effectiveness of the Valsalva maneuver was verified by a reduction of the middle cerebral artery flow velocity, in comparison with the basal spectrum. TCD was considered positive if at least one microembolic signal was recorded on TCD spectrum within 25 seconds from contrast injection. The shunt was defined as small (1, 10 microembolic signals), medium (>10 microembolic signals), or large (>10 microembolic signals with “curtain”).
Figure 1

Contrast TCD during the Valsalva maneuver. The middle cerebral artery was identified with color Doppler. The passage of contrast into the right middle cerebral artery (MCA).

Contrast TCD during the Valsalva maneuver. The middle cerebral artery was identified with color Doppler. The passage of contrast into the right middle cerebral artery (MCA).

Transesophageal echocardiography

The patients received local pharyngeal anesthesia with 10% topical lidocaine for TEE study. A TEE study was performed using a Toshiba Power Vision machine with a 5.0-MHz multiplane probe, according to a standard protocol including color flow Doppler data. The atrial septum was analyzed from the transverse mid-esophageal four-chamber view to the longitudinal biatrial-bicaval view (Figure 2). Since PFO was not clearly recognized by a bicaval view at 90° rotation, additional image planes (60°, 90° and/or 110°-130°) were used to better analyze the atrial septum. On TEE study, the effectiveness of the Valsalva maneuver was verified by a reduction in right ventricular and atrial size and by bulging of the atrial septum into the left atrium. To assess PFO, semi-quantification of the right to left shunt (RLS) was performed. On TEE the evaluation was based on counting the number of micro bubbles (MBs) moving from the right atrium to the left atrium through the PFO after the Valsalva maneuver, within the first three cardiac cycles. The studies were considered positive for PFO when at least one micro bubble was observed in the left atrium. The severity of the shunt was quantified as mild (<10 micro bubbles), moderate (10–20 micro bubbles), or severe (>20). If the quantitative results varied between the first and second study the largest number of MBs decided about the shunt size.
Figure 2

Contrast TEE during the Valsalva maneuver. Contrast agent in the left atrium.

Contrast TEE during the Valsalva maneuver. Contrast agent in the left atrium.

Statistical analysis

The SPSS 13.0 software package was used for statistical analysis. Quantitative data were expressed as the mean ± standard deviation, qualitative data as the percentage. The performance indexes used were sensitivity, specificity, predictive positive value (PPV), negative predictive value (NPV), and k concordance index, which express the agreement proportion beyond chance. Sensitivity was defined as: Specificity was defined as:

Results

Using both TCD and TEE, we detected a right-to-left shunt in 220 patients (52.3%) and no-shunts in 159 patients (37.9%). In 20 (4.8%) patients TEE did not show the passage of contrast which was later detected by TCD. In 21 (5.0%) patients only TEE revealed a PFO. The feasibility of both methods was 100%. Shunts confirmed by both methods (TCD and TEE) were found in: 78.4% of patients with cryptogenic stroke, in 48.6% of patients with TIA, and only in 10.4% of patients with migraine without aura (Table 2). Considering TEE as the gold standard technique, TCD was able to identify 200 (91.3%) of the 241 patients with PFO. TCD showed a NPV of 89%, PPV of 98%, sensitivity of 95%, and specificity of 92%. TCD showed a high concordance (k = 0.89) with TEE in PFO recognition (Table 3). Shunt grading in both TCD and TEE methods was classified with the same score in 70.5% of cases, and it was the highest in the large shunt (Table 4).
Table 2

Shunt grading using both transcranial doppler ultrasonography and transesophageal echocardiography

SHUNTTEE (N= 220 pts – TEE and TCD positive)TCD (N= 220 pts – TEE and TCD positive)% of the same grading using both methods
Small
56 (25.5%)
70 (31.8%)
62.1
Medium
123 (55.9%)
119 (54.1%)
68.3
Large41 (18.6%)31 (14.1%)83.2

TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography.

Table 3

Identification of persistent for amen ovale using both transcranial color doppler and transesophageal echocardiography

Clinical characteristics of patients
Identification of PFO (both TCD and TEE)
 Patients (n = 420)Patients (n = 220)
TIA
218 (51.9%)
106/218 (48.6%)
Migraine
67 (15.6%)
7/67 (10.4%)
Migraine with aura
50 (11.9%)
38/50 (76.0%)
Cryptogenic stroke88 (20.9%)69/88 (78.4%)

PFO Patent Foramen Ovale, TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography, TIA Transient Ischaemic Attack.

Table 4

Sensitivity, specificity, negative predictive value, and positive predictive value of transcranial doppler ultrasonography in comparison with transesophageal echocardiography in pfo detection

TechniquePFO (%)PPV (%)NPV (%)Sensitivity (%)Specificity (%)
Contrast-enhanced TCD9098899592

NPV: Negative Predictive Value, PPV: Negative Predictive Value TCD: Transcranial Doppler Ultrasonography, TEE: Transesophageal Echocardiography, PFO: Patent Foramen Ovale.

Shunt grading using both transcranial doppler ultrasonography and transesophageal echocardiography TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography. Identification of persistent for amen ovale using both transcranial color doppler and transesophageal echocardiography PFO Patent Foramen Ovale, TCD Transcranial Doppler Ultrasonography, TEE Transesophageal Echocardiography, TIA Transient Ischaemic Attack. Sensitivity, specificity, negative predictive value, and positive predictive value of transcranial doppler ultrasonography in comparison with transesophageal echocardiography in pfo detection NPV: Negative Predictive Value, PPV: Negative Predictive Value TCD: Transcranial Doppler Ultrasonography, TEE: Transesophageal Echocardiography, PFO: Patent Foramen Ovale.

Discussion

Patent foramen ovale is a hemodynamically trivial interatrial communication that is present in about 25% of the adult population. However, the clinical significance of PFO in relation to cerebrovascular events is still debated, identification and assessment of this abnormality are nowadays a routine diagnostic procedure [6,9-12]. The search for PFO is becoming more and more common in young subjects suffering from migraine, TIA or cryptogenic stroke [12-17]. At the moment there is no clearly recognized standard protocol for performing both TEE and TCD studies to identify PFO. For the first time, based on the available literature, we developed a standardized exercise protocol in both TEE and TCD studies. Contrast transesophageal echocardiography is the gold standard for the diagnosis of PFO, regardless of the fact that this procedure is semi-invasive [18-24]. Therefore, transcranial Doppler ultrasonography seems to be an attractive alternative to TEE in the recognition of PFO, because it is a cheap and noninvasive examination [25-29]. The aim of this study was to evaluate the feasibility of transcranial Doppler and its diagnostic sensitivity compared with transesophageal echocardiography. Although the diagnostic power of TCD has been reported, only a few studies comparing both techniques (TCD and TEE) have been published [5,30-33]. In our study TCD had a good sensitivity and specificity. In our opinion, in contrast to other investigators, TCD and TEE are complementary for PFO diagnosis, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost, and high feasibility. Contrary to other researchers, our results and clinical experience show that both methods are necessary and complementary to recognize a significant foramen ovale. The sensitivity and specificity of TCD for shunt detection vary in different studies according to both protocol and diagnostic criteria [25-33]. In our study TCD had 89% NPV, 98% PPV, 95% sensitivity, and 92% specificity. In the Caputi study a general concordance of up to 90% between TEE and TCD was found. TCD sensitivity and specificity were 96.8% and 78.4%, respectively [25]. Several studies have suggested that the low specificity of TCD may be due to the fact that TCD is able to detect both cardiac and pulmonary shunts [5]. The specificity for a PFO shunt may be increased by a defined time of micro bubble appearance. The passage time from the antecubital vein injection site to the middle cerebral artery (MCA) through an intracardiac shunt is about 11 seconds, and it is about 14 seconds in the case of pulmonary passage. The overlap interval between intrapulmonary and cardiac passage level must be taken into account [33]. In our study only in 4.8% of patients TEE did not show the passage of contrast which was later detected by TCD. The meaning of a shunt detected only during TCD is not clearly understood, but a very small intracardiac shunt, not detected by TEE, cannot be excluded. Furthermore the Valsalva maneuver may be less effective during TEE than during TCD, because of esophageal intubation. It is crucial to perform the Valsalva maneuver properly. Contrary to other investigators, in our material, the patients had been trained in performing the Valsalva maneuver before study. Recent studies as well as our results (95% sensitivity, and 92% specificity of TCD), show a good concordance between TCD and TEE with sensitivity ranging from 70% to 100% and specificity >95% [27,31,32]. Both techniques have class IIA recommendations for shunt detection [33]. Taking into account that TCD and TEE have similar sensitivity and specificity in shunt detection TCD should be recommended as the first choice for screening because of its low cost, and high feasibility. TCD is also a noninvasive exam - easy to perform and repeat, if necessary. TEE should be limited to the patients scheduled for transcatheter PFO closure, patients with high-risk PFO with recurrent stroke, and patients with ASA or large shunt detected on TCD.

Conclusion

TCD has a relatively good sensitivity and specificity. TCD and TEE are complementary for PFO diagnosis, but TCD should be recommended as the first choice for screening because of its simplicity, non-invasive character, low cost, and high feasibility.

Abbreviations

MBs: Micro bubbles; MCA: Middle cerebral artery; NPV: Negative predictive value; PFO: Persistent foramen ovale; PPV: Positive predictive value; RLS: Right to left shunt; TCD: Transcranial color doppler; TEE: Transesophageal echocardiography; TIA: Transient ischaemic attack; TTE: Transthoracic echocardiography.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MK: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. MO: contributed to study conception and design, helped to draft the manuscript, revising it critically. TP: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content, gave final approval of the version to be published. JP: contributed to study conception and design, analysis and interpretation of data. JS: analysis and interpretation of data, drafting the manuscript. BS: contributed to study conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript. RB: contributed in revising critically for important intellectual content. AKZ: analysis and interpretation of data, revising it critically for important intellectual content. LTP: contributed in acquisition of data, analysis and interpretation of data, drafting the manuscript, revising it critically for important intellectual content. PP: contributed to study conception and design, revising it critically for important intellectual content, gave final approval of the version to be published. All author’s read approved the final manuscript.
  33 in total

1.  Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale.

Authors:  Gérald Devuyst; Bartlomiej Piechowski-Józwiak; Theodoros Karapanayiotides; Jean-William Fitting; Vendel Kémeny; Lorenz Hirt; Luis A Urbano; Pierre Arnold; Guy van Melle; Paul-Andre Despland; Julien Bogousslavsky
Journal:  Stroke       Date:  2004-02-26       Impact factor: 7.914

2.  Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning.

Authors:  Ervin R Fox; Michael H Picard; Chi-Ming Chow; Robert A Levine; Lee Schwamm; Andrew J Kerr
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

3.  Transthoracic echocardiography using second harmonic imaging: diagnostic alternative to transesophageal echocardiography for the detection of atrial right to left shunt in patients with cerebral embolic events.

Authors:  H P Kühl; R Hoffmann; M W Merx; A Franke; C Klötzsch; W Lepper; T Reineke; J Noth; P Hanrath
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

Review 4.  Patent foramen ovale: a review of associated conditions and the impact of physiological size.

Authors:  E K Kerut; W T Norfleet; G D Plotnick; T D Giles
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

5.  Contrast transcranial doppler ultrasound in the detection of right-to-left shunts : time window and threshold in microbubble numbers.

Authors:  D W Droste; K Silling; J Stypmann; M Grude; V Kemény; T Wichter; K Kühne; E B Ringelstein
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

6.  Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.

Authors:  Shunichi Homma; Ralph L Sacco; Marco R Di Tullio; Robert R Sciacca; J P Mohr
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  [Prevalence of patent foramen ovale in young patients with cerebral ischemic accident of unknown origin].

Authors:  Dolores Mesa; Manuel Franco; José Suárez de Lezo; Juan Muñoz; Carmen Rus; Mónica Delgado; Martín Ruiz; Manuel Pan; Elías Romo; Federico Vallés; Monserrat Viñals; Enrique Bescansa
Journal:  Rev Esp Cardiol       Date:  2003-07       Impact factor: 4.753

Review 8.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.

Authors:  Ulrike Krumsdorf; Stefan Ostermayer; Kai Billinger; Thomas Trepels; Elisabeth Zadan; Kathrin Horvath; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

9.  Prevalence of atrial septal aneurysm in patients with migraine: an echocardiographic study.

Authors:  S Carerj; M C Narbone; C Zito; S Serra; S Coglitore; P Pugliatti; F Luzza; F Arrigo; G Oreto
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

10.  Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts.

Authors:  Dirk W Droste; Stefan Lakemeier; Thomas Wichter; Jörg Stypmann; Ralf Dittrich; Martin Ritter; Martin Moeller; Michael Freund; E Bernd Ringelstein
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more
  15 in total

1.  Transcranial Doppler in the blue stander: the platypnoea-orthodeoxia syndrome revisited.

Authors:  Jose Antonio Egido; Ana Maria Garcia
Journal:  BMJ Case Rep       Date:  2014-10-20

2.  Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale.

Authors:  Jiang-Chun He; Jian-Yong Zheng; Xin Li; Ye Yang; Bo-Yang Zhang; Yu Chen; Xian-Feng Li; Ying-Ming Liu; Yi Cao; Li Zhao; Tian-Chang Li
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-07       Impact factor: 2.357

3.  The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.

Authors:  Benjamin S Wessler; David M Kent; David E Thaler; Robin Ruthazer; Jennifer S Lutz; Joaquín Serena
Journal:  Cerebrovasc Dis       Date:  2015-07-11       Impact factor: 2.762

4.  Detecting Patent Foramen Ovale after Cryptogenic Stroke - A Single Center Experience in Taiwan.

Authors:  Ting-Yu Lin; Yun-Ching Fu; Sheng-Ling Jan; Ming-Chih Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

5.  Clinical and imaging characteristics of PFO-related stroke with different amounts of right-to-left shunt.

Authors:  Dan He; Qian Li; Guangjin Xu; Zheng Hu; Xuefei Li; Yinping Guo; Shabei Xu; Wei Wang; Xiang Luo
Journal:  Brain Behav       Date:  2018-10-11       Impact factor: 2.708

6.  Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study.

Authors:  Ramazan Atak; Mehmet Ileri; Selcuk Ozturk; Ahmet Korkmaz; Ertan Yetkin
Journal:  Cardiol Res Pract       Date:  2019-04-01       Impact factor: 1.866

7.  Modified Method of Contrast Transthoracic Echocardiography for the Diagnosis of Patent Foramen Ovale.

Authors:  Enfa Zhao; Yajuan Du; Hang Xie; Yushun Zhang
Journal:  Biomed Res Int       Date:  2019-05-09       Impact factor: 3.411

8.  A Comparison of Transthroracic Echocardiograpy and Transcranial Doppler With Contrast Agent for Detection of Patent Foramen Ovale With or Without the Valsalva Maneuver.

Authors:  Enfa Zhao; Yajuan Wei; Yafei Zhang; Nina Zhai; Ping Zhao; Baomin Liu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  Comparison of Different Contrast Agents in Detecting Cardiac Right-to-Left Shunt in Patients with a Patent Foramen Ovale during Contrast-Transthoracic Echocardiography.

Authors:  Enfa Zhao; Gesheng Cheng; Yushun Zhang; Yang Li; Yingli Wang
Journal:  Biomed Res Int       Date:  2017-12-03       Impact factor: 3.411

10.  Clinical and infarction patterns of PFO-related cryptogenic strokes and a prediction model.

Authors:  Dan He; Qiang Shi; Guangjing Xu; Zheng Hu; Xuefei Li; Qian Li; Yinping Guo; Shabei Xu; Yongbo Lin; Zhiyuan Yu; Wei Wang; Xiang Luo
Journal:  Ann Clin Transl Neurol       Date:  2018-09-24       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.